Table 2

Patient characteristics and patient outcome in 142 units providing SDPs compared with 97 units not providing SDPs

Statistic142 Units providing SDPs97 Units not providing SDPsp Value (Mann–Whitney)
Unit variationUnit variation
Median (IQR)Median (IQR
Number of audit patients49 (29–59)45 (30–56)0.48
Mean age, years73 (71–74)73 (71–75)0.23
Median FEV1, % predicted39 (35–43)37 (34–43)0.19
Current smokers, %33 (28–42)32 (26–39)0.30
Median LOS in hospital, days*5 (4–6)6 (5–7)0.003
Hospital LOS ≥7 days, %41 (31–48)44 (37–53)0.008
Mortality (inpatient), %5.7 (3.0–8.5)8.8 (6.3–12.1)<0.001
Mortality (90 days of admission), %*12.5 (6.7–17.0)16.3 (11.9–20.7)<0.001
Readmission (90 days of admission), %*35 (25–42)32 (23–39)0.22
Median pH on admission7.41 (7.39–7.42)7.41 (7.39–7.42)0.73
pH on admission <7.35, %19 (13–25)21 (16–26)0.04
pO2 on admission8.9 (8.5–9.5)9.0 (8.5–9.5)0.38
pO2 on admission ≤8.0 kPa, %35 (27–40)35 (27–42)0.70
Chest radiograph with changes15 (8–23)14 (9–22)0.78
consistent with pneumonia, %
Lives alone in house/flat, %33 (28–41)37 (32–42)0.03
One or more significant medical conditions, %79 (69–86)79 (70–87)0.75
Three or more significant medical conditions, %18 (11–27)19 (11–26)0.64
Received NIV during hospital stay, %8 (4–14)13 (7–17)0.001
  • * Denotes data relating to British Thoracic Society audit criteria.

  • Comorbidities included ischaemic heart disease, left ventricular failure, cor pulmonale, lung cancer or other malignant diseases, cardiac arrhythmia—for example atrial fibrillation, locomotor problems, stroke, diabetes, visual impairment, neurological conditions, alcohol-related conditions, psychiatric conditions, thromboembolic disease—for example pulmonary embolism or deep vein thrombosis, gastrointestinal conditions or endocrine disorders.

  • FEV1, forced expiratory volume in 1 s; LOS, length of stay; NIV, non-invasive ventilation; pO2, partial pressure of oxygen; SDP, supported discharge programme.